Which way will CCXI go? Request
Analyst Ratings Last 30 days
Stop-loss: $13.87 (-6.17%)
Price TargetJuly 07, 2021 2
Low Average High
$79.00 $79.00 $79.00
Earnings Date: August 09, 2021
* uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 30 and the stock is currently not being overbought or oversold

ChemoCentryx stock price down 1.27% on Friday (Updated on July 30, 2021)

Hold candidate since 2021-07-28 Loss -4.71%

The ChemoCentryx stock price fell by -1.27% on the last day (Friday, 30th Jul 2021) from $14.97 to $14.78. and has now fallen 3 days in a row. During the day the stock fluctuated 4.11% from a day low at $14.61 to a day high of $15.21. The price has fallen in 6 of the last 10 days and is down by -6.75% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -338 thousand shares and in total, 922 thousand shares were bought and sold for approximately $13.62 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.98% during the next 3 months and, with a 90% probability hold a price between $8.45 and $16.28 at the end of this 3-month period.

Signals & Forecast

The ChemoCentryx stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $14.83. On a fall, the stock will find some support from the long-term average at approximately $14.42. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, July 12, 2021, and so far it has fallen -14.76%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 months Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss

ChemoCentryx finds support from accumulated volume at $14.05 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.60 between high and low, or 4.11%. For the last week, the stock has had a daily average volatility of 5.66%.

Our recommended stop-loss: $13.87 (-6.17%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 14 day(s) ago.)

Is ChemoCentryx stock A Buy?

ChemoCentryx holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.245

Predicted Opening Price for ChemoCentryx of Monday, August 2, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price August 2, 2021 Current price
$14.87 $14.78 (Undervalued)
Hold/Accumulate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

Canaccord Genuity is very positive about CCXI and gave it a "Buy" rating on July 07, 2021. The price target was set to $79.00. Over the last 30 days, this security got 2 buy, 0 sell, and 0 hold ratings.

5.66 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $15.10
Price: $14.78
Support: $14.05

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 15.47 4.65 %
15.24 3.10 %
15.10 2.14 %
Current price: 14.78
Support 14.64 -0.96 %
14.50 -1.92 %
14.27 -3.47 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 17.34 17.32 %
16.77 13.46 %
15.10 2.17 %
Current price 14.78
Support 14.05 -4.94%
13.51 -8.59%
13.17 -10.89%

Click to get the best stock tips daily for free!

About ChemoCentryx

ChemoCentryx ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered therapeutics to treat orphan and rare diseases, autoimmune diseases, inflammatory disorders, and cancer in the United States. Its lead drug candidates in clinical development include CCX168, which is in Phase II clinical trials for the treatment of orphan and rare diseases; CCX872, which is in Phase I... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE